Alta Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.2M Buy
307,717
+19,130
+7% +$1.32M 1.21% 29
2025
Q1
$20M Buy
288,587
+84,358
+41% +$5.86M 1.3% 28
2024
Q4
$17.6M Sell
204,229
-602
-0.3% -$51.8K 1.05% 30
2024
Q3
$24.4M Buy
204,831
+94,919
+86% +$11.3M 1.45% 28
2024
Q2
$15.7M Buy
+109,912
New +$15.7M 0.99% 33
2019
Q3
Sell
-14,572
Closed -$371K 100
2019
Q2
$371K Sell
14,572
-20,906
-59% -$532K 0.02% 71
2019
Q1
$927K Sell
35,478
-1,686,672
-98% -$44.1M 0.05% 59
2018
Q4
$39.7M Sell
1,722,150
-16,144
-0.9% -$372K 2.57% 16
2018
Q3
$41M Buy
1,738,294
+55,926
+3% +$1.32M 2.27% 21
2018
Q2
$38.8M Sell
1,682,368
-2,260
-0.1% -$52.1K 2.39% 18
2018
Q1
$41.5M Sell
1,684,628
-18,584
-1% -$458K 2.58% 19
2017
Q4
$45.7M Sell
1,703,212
-26,568
-2% -$713K 2.88% 16
2017
Q3
$41.6M Sell
1,729,780
-34,686
-2% -$835K 2.69% 17
2017
Q2
$37.8M Sell
1,764,466
-80,258
-4% -$1.72M 2.56% 20
2017
Q1
$31.6M Buy
1,844,724
+185,018
+11% +$3.17M 2.12% 24
2016
Q4
$29.8M Sell
1,659,706
-160,538
-9% -$2.88M 2.13% 23
2016
Q3
$37.9M Buy
1,820,244
+20,298
+1% +$422K 2.36% 22
2016
Q2
$48.4M Buy
1,799,946
+32,446
+2% +$872K 2.99% 11
2016
Q1
$47.9M Buy
1,767,500
+394,292
+29% +$10.7M 2.95% 14
2015
Q4
$39.9M Buy
1,373,208
+50,850
+4% +$1.48M 3.22% 8
2015
Q3
$35.9M Buy
1,322,358
+8,864
+0.7% +$240K 3.05% 11
2015
Q2
$36M Buy
1,313,494
+11,250
+0.9% +$308K 2.95% 8
2015
Q1
$34.8M Sell
1,302,244
-725,464
-36% -$19.4M 2.96% 8
2014
Q4
$42.9M Buy
2,027,708
+50,940
+3% +$1.08M 3.58% 3
2014
Q3
$47.1M Sell
1,976,768
-20,534
-1% -$489K 4.36% 2
2014
Q2
$46.1M Buy
1,997,302
+28,240
+1% +$652K 4.25% 2
2014
Q1
$44.9M Buy
1,969,062
+58,022
+3% +$1.32M 4.35% 2
2013
Q4
$35.3M Buy
1,911,040
+102,400
+6% +$1.89M 3.62% 3
2013
Q3
$30.6M Buy
1,808,640
+71,460
+4% +$1.21M 3.68% 3
2013
Q2
$26.9M Buy
+1,737,180
New +$26.9M 3.64% 3